| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/IMR.12524 |
| P698 | PubMed publication ID | 28258699 |
| P2093 | author name string | Chen Dong | |
| Ling Ni | |||
| P2860 | cites work | The coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer | Q34093668 |
| Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis | Q38966400 | ||
| P433 | issue | 1 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 52-65 | |
| P577 | publication date | 2017-03-01 | |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | New checkpoints in cancer immunotherapy | |
| P478 | volume | 276 |
| Q93006569 | Analysis of VISTA expression and function in renal cell carcinoma highlights VISTA as a potential target for immunotherapy |
| Q90681858 | B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3 |
| Q60933076 | Cancer research in the era of immunogenomics |
| Q55438414 | Cardiotoxicity of immune checkpoint inhibitors. |
| Q92857847 | Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies |
| Q46971015 | Checkpoint blockade in solid tumors and B-cell malignancies, with special consideration of the role of CD200. |
| Q47130162 | Detection of programmed death ligand 1 protein and CD8+ lymphocyte infiltration in plurihormonal pituitary adenomas: A case report and review of the literatures |
| Q93167035 | Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix |
| Q64953733 | Expression of V-domain immunoglobulin suppressor of T cell activation is associated with the advanced stage and presence of lymph node metastasis in ovarian cancer. |
| Q54238201 | Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability. |
| Q91728737 | Harnessing tumor-associated macrophages as aids for cancer immunotherapy |
| Q92289777 | High CD3 and ICOS and low TIM-3 expression predict favourable survival in resected oesophageal squamous cell carcinoma |
| Q47171882 | Immune Checkpoints in Leprosy: Immunotherapy As a Feasible Approach to Control Disease Progression |
| Q98386332 | Immune disorder in endometrial cancer: Immunosuppressive microenvironment, mechanisms of immune evasion and immunotherapy |
| Q87944374 | Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies |
| Q92176250 | Immunotherapy and targeted therapy combinations in metastatic breast cancer |
| Q55293126 | Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen. |
| Q47290509 | Informatics for cancer immunotherapy |
| Q50077700 | Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours |
| Q42366666 | Long non-coding RNAs associated with non-small cell lung cancer |
| Q58572875 | Molecular Mechanisms Directing Migration and Retention of Natural Killer Cells in Human Tissues |
| Q48201416 | Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan-cancer survey with implications for the use of immune checkpoint inhibitors. |
| Q47221234 | New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness |
| Q53834241 | Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma. |
| Q64923698 | Risk of dermatologic and mucosal adverse events associated with PD-1/PD-L1 inhibitors in cancer patients: A meta-analysis of randomized controlled trials. |
| Q48203955 | Sex disparity in cancer: roles of microRNAs and related functional players. |
| Q59807641 | Soluble immune checkpoints in cancer: production, function and biological significance |
| Q60920815 | Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy |
| Q52572072 | The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy. |
| Q89457645 | Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology |
| Q90660423 | VISTA: a novel immunotherapy target for normalizing innate and adaptive immunity |
Search more.